Article Information
History
- November 1, 2022.
Article Versions
- You are currently viewing Version 1 of this article (November 1, 2022 - 09:12).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Jennifer A Rybak1,
- Amita R Sahoo2,
- Soyeon Kim3,
- Robert J Pyron4,
- Savannah B Pitts4,
- Saffet Guleryuz5,
- Adam W Smith3,6,
- Matthias Buck2 and
- Francisco N Barrera4,*
- 1Department of Genome Sciences and Technology, University of Tennessee, 1311 Cumberland Avenue, Knoxville, TN 37996, USA
- 2Department of Physiology and Biophysics, Case Western Reserve University, School of Medicine, 10900 Euclid Avenue, Cleveland, OH 44106, USA
- 3Department of Chemistry, University of Akron, 190 Buchtel Common, Akron, Ohio 44325, USA
- 4Department of Biochemistry & Cellular and Molecular Biology, University of Tennessee, 1311 Cumberland Avenue, Knoxville, TN 37996, USA
- 5Department of Medicine, University of Tennessee Graduate School of Medicine, 1924 Alcoa Hwy, Knoxville, TN, 37920, USA
- 6Department of Chemistry and Biochemistry, Texas Tech University, 2500 Broadway St, Lubbock, TX 79409
- ↵*Corresponding author; email: fbarrera{at}utk.edu
Posted November 01, 2022.
Allosteric inhibition of the epidermal growth factor receptor through disruption of transmembrane interactions
